Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ALVO is expected to report earnings to fall 73.33% to -2 cents per share on August 19
Q2'26
Est.
$-0.02
Q1'26
Missed
by $0.09
Q4'25
Beat
by $0.09
Q3'25
Beat
by $0.50
Q2'25
Beat
by $0.50
The last earnings report on May 06 showed earnings per share of -9 cents, missing the estimate of 0 cents. With 989.43K shares outstanding, the current market capitalization sits at 1.22B.